На этой странице перечислены больницы направления «Кардиология» (включая Electrophysiology Study) в Бангалор, Индия, включая Narayana Health, Manipal Hospitals, Medicover Hospital, Bangalore, Gleneagles Hospitals, Bengaluru и другие.
Спросите нас о «Electrophysiology Study» в Бангалор, Индия
Оставьте свои данные — наша команда координации свяжется с вами и расскажет о следующих шагах.
Сравните 10 аккредитованных больниц (Кардиология) в Бангалор, Индия
Рекомендуем🇮🇳 Narayana Health
Больница занимает 1-е место в этом списке по указанному рейтингу (4.8/5, 1750 отзывов).
🇮🇳 Manipal Hospitals
Больница занимает 2-е место в этом списке по указанному рейтингу (4.7/5, 1450 отзывов).
🇮🇳 Medicover Hospital, Bangalore
Больница занимает 3-е место в этом списке по указанному рейтингу (4.7/5, 68 отзывов).
🇮🇳 Gleneagles Hospitals, Bengaluru
Больница занимает 4-е место в этом списке по указанному рейтингу (4.7/5, 142 отзывов).
🇮🇳 Manipal Hospital Malleshwaram (Northside)
Больница занимает 5-е место в этом списке по указанному рейтингу (4.6/5, 71 отзывов).
🇮🇳 Manipal Hospital, Old Airport Road
Больница занимает 6-е место в этом списке по указанному рейтингу (4.5/5, 87 отзывов).
🇮🇳 Manipal Hospital Yeshwanthpur (Columbia Asia)
Больница занимает 7-е место в этом списке по указанному рейтингу (4.5/5, 98 отзывов).
🇮🇳 Manipal Hospital Millers Road (Vikram Hospital)
Больница занимает 8-е место в этом списке по указанному рейтингу (4.4/5, 74 отзывов).
🇮🇳 Apollo Hospital, Bannerghatta Road
Больница занимает 9-е место в этом списке по указанному рейтингу (4.2/5, 25 отзывов).
🇮🇳 Fortis Hospital, Bannerghatta Road
Больница занимает 10-е место в этом списке по указанному рейтингу (4.2/5, 58 отзывов).
Как мы выбираем эти больницы
Больница появляется на этой странице, если направление «Кардиология» указано среди её специализаций и она находится в Бангалор, Индия. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».
Как выбрать лучшую больницу для «electrophysiology study» в Бангалор, Индия?
Выбор подходящей больницы для «electrophysiology study» — важное решение в вашем пути лечения. Вот на что стоит обратить внимание:
Международная аккредитация
Ищите больницу с международной аккредитацией, например JCI или NABH — см. отметки аккредитации у каждой больницы ниже.
Специализация
Убедитесь, что в больнице есть отделение, специализирующееся на «Кардиология», а не только общая помощь.
Мощность и опыт
Количество коек и год основания, указанные ниже, отражают масштаб и операционный опыт больницы.
Прозрачность стоимости
Запросите детализированную смету перед поездкой — используйте наш калькулятор стоимости для первичной оценки.
Что нужно знать о процедуре «Electrophysiology Study»
An Electrophysiology Study (EPS) is a minimally invasive cardiac diagnostic procedure that maps the heart's electrical conduction system to identify the precise origin and mechanism of arrhythmias, including atrial fibrillation, ventricular tachycardia, Wolff-Parkinson-White syndrome, and unexplained syncope. Performed by board-certified cardiac electrophysiologists in state-of-the-art catheterization laboratories, the diagnostic accuracy of EPS exceeds 95% when combined with modern 3D electroanatomical mapping systems such as CARTO 3 or EnSite X. GAF Healthcare facilitates access to JCI- and NABH-accredited hospitals in India and JCI- and DHA-licensed centers in Dubai and Abu Dhabi, offering international patients world-class electrophysiology expertise at a fraction of Western costs, with full concierge support from initial consultation through discharge. Hospital Stay: 1–2 days (diagnostic EPS alone); 2–4 days if combined with catheter ablation • Total Stay in Country (Fit-to-Fly): 3–7 days post-procedure for diagnostic EPS; 7–14 days if ablation was performed concurrently • Success Rate: 95–98% diagnostic accuracy for arrhythmia localization; 85–95% long-term success when followed by radiofrequency or cryoablation depending on arrhythmia type
Clinical Overview
The heart's rhythm is governed by a specialized electrical conduction system comprising the sinoatrial (SA) node, atrioventricular (AV) node, Bundle of His, right and left bundle branches, and the Purkinje fiber network. When this system is disrupted — whether by structural remodeling, fibrosis, accessory pathways, or ion-channel dysfunction — patients experience arrhythmias that range from mildly symptomatic palpitations to life-threatening ventricular fibrillation. Conditions such as atrial flutter, AV nodal re-entrant tachycardia (AVNRT), Wolff-Parkinson-White (WPW) syndrome, idiopathic ventricular tachycardia, and Brugada syndrome all require precise electrophysiological characterization before a definitive treatment strategy — ablation, antiarrhythmic pharmacotherapy, or implantable cardioverter-defibrillator (ICD) implantation — can be safely planned. An Electrophysiology Study (EPS) is the gold-standard invasive diagnostic test for evaluating these conditions. Under fluoroscopic guidance and, increasingly, three-dimensional electroanatomical navigation (CARTO 3, EnSite X NavX, or Rhythmia HDx), the electrophysiologist advances thin, flexible multipolar electrode catheters via femoral, subclavian, or jugular venous access into the right atrium, right ventricle, His bundle region, and coronary sinus. Intracardiac electrograms are recorded at each site, and the conduction system is interrogated through programmed electrical stimulation (PES) — delivering precisely timed extrastimuli to induce and characterize the clinical arrhythmia under controlled, immediately reversible conditions. The global standard of care now integrates EPS with high-density contact mapping and, where clinically indicated, same-session catheter ablation — radiofrequency energy (RF), cryoablation, or the emerging pulsed-field ablation (PFA) technology — converting a purely diagnostic encounter into a curative intervention. Leading cardiac electrophysiology centers in India (such as those in Mumbai, Delhi, Chennai, Hyderabad, and Bangalore) and in the UAE (Dubai and Abu Dhabi) have adopted this integrated approach, supported by intracardiac echocardiography (ICE), remote magnetic navigation (Niobe II/Genesis), and AI-assisted arrhythmia interpretation software, placing their outcomes on par with European and North American centers.
Who is a Candidate?
• ELIGIBLE PATIENTS: • Patients with documented or suspected supraventricular tachycardia (SVT), including AVNRT, AVRT, and atrial flutter, that is symptomatic or refractory to at least one antiarrhythmic drug • Patients with Wolff-Parkinson-White (WPW) syndrome, especially those with pre-excitation and syncope, to risk-stratify and ablate accessory pathways • Patients with unexplained syncope or pre-syncope where non-invasive testing (Holter, tilt-table test, event monitor) has been inconclusive • Patients with sustained or non-sustained ventricular tachycardia (VT) for substrate mapping and ablation planning • Patients with known structural heart disease (prior myocardial infarction, dilated cardiomyopathy, ARVC) being evaluated for ICD implantation or VT ablation • Patients with high-degree AV block or suspected sinus node dysfunction requiring precise localization (AH and HV interval measurement) • Survivors of sudden cardiac arrest without a clear reversible cause • Patients with Brugada syndrome or Long QT syndrome requiring risk stratification • Pre-ablation mapping prior to planned surgical maze procedure • REQUIRED PRE-PROCEDURE DIAGNOSTICS: • 12-lead resting ECG and 24–72-hour ambulatory Holter monitoring • Transthoracic Echocardiogram (TTE/ECHO) to assess structural heart disease, ejection fraction, and valvular pathology • Cardiac MRI (CMR) with late gadolinium enhancement (LGE) for scar mapping in structural VT patients • Exercise stress testing or pharmacological provocation (ajmaline/flecainide challenge for Brugada, epinephrine for LQTS) • Complete blood count, coagulation profile (PT/INR/aPTT), renal function panel, and electrolytes • Thyroid function tests (TSH, FT4) in patients with atrial fibrillation • Chest X-ray and baseline CT angiography if pulmonary vein isolation (PVI) is anticipated • CONTRAINDICATIONS: • Active systemic infection or bacteremia (risk of seeding intracardiac catheter) • Uncontrolled heart failure with hemodynamic instability • Recent acute myocardial infarction (within 4 weeks, unless emergent) • Uncorrected coagulopathy or therapeutic anticoagulation that cannot be safely bridged • Severe peripheral arterial disease precluding femoral access • Known intracardiac thrombus (particularly left atrial appendage thrombus on pre-procedure TEE or CT) — requires thrombus resolution before left-sided procedures • Severe, uncorrected electrolyte disturbances • Allergy to contrast media or heparin (requires individualized protocol modification)
Treatment Options & Approaches
DIAGNOSTIC EPS (STANDARD): The foundational EPS protocol involves placement of 3–4 multipolar electrode catheters under fluoroscopy in the high right atrium, His bundle position, right ventricular apex, and coronary sinus. Baseline intervals are measured — PA interval (intra-atrial conduction), AH interval (AV nodal conduction, normal 55–130 ms), and HV interval (His-Purkinje conduction, normal 35–55 ms). Programmed electrical stimulation (PES) with single and double extrastimuli at multiple drive cycle lengths is used to assess sinus node recovery time (SNRT), AV node Wenckebach cycle length, and to induce arrhythmia. Pharmacological provocation with isoproterenol, adenosine, or procainamide is employed to unmask latent pathways or conduction disease. 3D ELECTROANATOMICAL MAPPING (ADVANCED): Modern EPS integrates real-time 3D electroanatomical mapping (EAM) using CARTO 3 (Biosense Webster), EnSite X NavX (Abbott), or Rhythmia HDx (Boston Scientific). These platforms construct point-by-point or ultra-high-density contact maps of the cardiac chamber, coloring activation sequences (activation mapping), voltage amplitude (voltage mapping to identify scar), and pace-mapping fidelity. Ultra-high-density mapping catheters — such as the PentaRay (64 electrodes), Advisor HD Grid (16 electrodes with omnipolar technology), or Orion basket catheter (64 electrodes) — acquire thousands of electrograms in minutes, dramatically improving the accuracy of substrate identification and ablation target localization. CATHETER ABLATION (THERAPEUTIC — SAME SESSION OR STAGED): • Radiofrequency Ablation (RFA): Delivery of 350–750 kHz alternating current via a 4 mm tip or irrigated-tip (3.5 mm) ablation catheter creates resistive heating and a discrete lesion (5–7 mm diameter, 3–5 mm depth). Irrigated-tip catheters (ThermoCool SmartTouch with contact-force sensing) allow deeper lesions with reduced char formation. Used for AVNRT, accessory pathways, atrial flutter (cavotricuspid isthmus), and VT. • Cryoablation: The Arctic Front Advance (Medtronic) balloon catheter delivers cryoenergy (–60°C to –75°C) for pulmonary vein isolation in atrial fibrillation. Preferred in patients with anatomically favorable pulmonary vein ostia; associated with lower risk of atrioesophageal fistula compared to point-by-point RF. • Pulsed-Field Ablation (PFA): The newest paradigm — the Farapulse (Boston Scientific) and Volt system — delivers ultrashort, high-voltage electric field pulses that cause irreversible electroporation selectively in cardiomyocytes, sparing the esophagus, phrenic nerve, and pulmonary veins. PFA dramatically shortens procedure time and is being rapidly adopted at leading Indian and UAE centers. • Remote Magnetic Navigation (Niobe Genesis, Stereotaxis): A robotic catheter guidance system allowing precise, force-controlled catheter movements in complex anatomies (congenital heart disease, epicardial VT). Available at select tier-1 Indian centers. IMPLANTABLE DEVICE IMPLANTATION (POST-EPS): When EPS reveals significant sinus node dysfunction, high-degree AV block, or inducible sustained VT/VF in high-risk patients, same-admission device implantation may follow: permanent pacemaker (PPM), implantable cardioverter-defibrillator (ICD — single/dual-chamber or CRT-D for heart failure patients), or subcutaneous ICD (S-ICD, Boston Scientific) if venous access is unsuitable. Leadless pacemakers (Micra AV/VR, Medtronic) are increasingly used for AV block when venous implant is contraindicated.
Восстановление
STEP 1 — PRE-TRAVEL CONSULTATION (2–4 weeks before travel): GAF Healthcare coordinates a secure telemedicine consultation between the patient and the designated cardiac electrophysiologist. All prior records — ECGs, Holter reports, echocardiogram, cardiac MRI, and medication lists — are reviewed. The EP team determines whether the planned procedure will be diagnostic-only EPS or integrated EPS + ablation. Anticoagulation bridging protocol is communicated (e.g., holding warfarin 3–5 days pre-procedure; NOAC-hold strategy for 24–48 hours depending on agent and renal function). STEP 2 — ARRIVAL & PRE-PROCEDURE WORKUP (Day 0–1): The patient arrives and is admitted. A dedicated GAF Healthcare coordinator escorts the patient from the airport. Same-day or next-morning pre-procedure bloodwork, 12-lead ECG, ECHO, and anesthesiology assessment are completed. Transesophageal echocardiogram (TEE) or cardiac CT angiography is performed if pulmonary vein isolation or left-sided ablation is planned, to exclude left atrial thrombus. NPO (nothing by mouth) begins 6–8 hours before the procedure. STEP 3 — THE PROCEDURE (Day 1–2, Duration: 1–5 hours): The patient is brought to the electrophysiology (EP) lab. Conscious sedation (midazolam + fentanyl) or general anesthesia (preferred for complex VT ablation, AF ablation, or pediatric cases) is administered. Venous sheaths (6F–9F) are placed in the right femoral vein under ultrasound guidance. For left-sided procedures, transseptal puncture (Brockenbrough technique, confirmed by intracardiac echo or fluoroscopy) allows access to the left atrium. Systemic anticoagulation with unfractionated heparin is titrated to achieve ACT >300 seconds. Catheter mapping, arrhythmia induction, and ablation proceed per the mapped strategy. Hemostasis is achieved post-sheath removal with manual compression or a vascular closure device (Angio-Seal, Perclose ProGlide). STEP 4 — IMMEDIATE POST-PROCEDURE MONITORING (Day 1–2): The patient is transferred to the cardiac step-down unit or cardiac ICU for continuous telemetry monitoring. Bed rest for 4–6 hours (femoral access) with limb immobilization is maintained. Post-procedure 12-lead ECG, chest X-ray (to exclude pneumothorax or pericardial effusion), and groin site inspection are performed. Heparin bridging or reinitiation of oral anticoagulation follows the EP team's protocol. Oral antiarrhythmics (if any) are reassessed. STEP 5 — HOSPITAL DISCHARGE (Day 2–4): For uncomplicated diagnostic EPS, discharge typically occurs within 24 hours. Following successful ablation (AVNRT, AFL, WPW), discharge within 24–48 hours is standard. Complex VT ablation or AF ablation with PFA/cryo requires 2–4 days of observation. A comprehensive discharge summary, procedure report with 3D map images, and the electrophysiologist's follow-up plan are provided in English for continuity of care at the patient's home institution. STEP 6 — POST-DISCHARGE & FIT-TO-FLY PERIOD (Days 3–14): Patients are seen in outpatient follow-up 2–5 days post-discharge for wound check and arrhythmia assessment (ECG, brief monitor). For diagnostic-only EPS, patients are typically cleared to fly within 3–5 days. Following ablation, a 7–10 day in-country recovery is recommended before long-haul flight, with compression stockings and adequate hydration advised. GAF Healthcare arranges serviced apartment accommodation near the hospital for this period. STEP 7 — LONG-TERM RECOVERY (1–3 months): A blanking period of 3 months is observed after AF ablation, during which recurrent arrhythmias do not necessarily indicate procedural failure — antiarrhythmic drugs are commonly continued for 3 months post-ablation. Remote cardiac monitoring (implantable loop recorder or wearable patch monitor) may be prescribed. A 3-month telemedicine follow-up with the operating electrophysiologist is coordinated by GAF Healthcare.
Возможные риски
An Electrophysiology Study is generally considered a low-risk procedure when performed in a high-volume center by an experienced cardiac electrophysiologist, with an overall major complication rate below 1–2% for diagnostic studies. However, patients and referring physicians should be aware of the following specific risks: VASCULAR ACCESS COMPLICATIONS: Hematoma, pseudoaneurysm, arteriovenous fistula, or retroperitoneal bleeding at the femoral access site occur in 1–3% of cases. Risk is mitigated by ultrasound-guided venipuncture and use of vascular closure devices. CARDIAC PERFORATION AND TAMPONADE: Inadvertent perforation of the right atrial or right ventricular free wall by stiff catheters can cause hemopericardium and cardiac tamponade (0.1–1%). All EPS labs must maintain immediate pericardiocentesis capability. AV BLOCK: Inadvertent ablation injury to the AV node or His bundle during AVNRT ablation carries a risk of complete heart block requiring permanent pacemaker implantation of approximately 0.2–1%. Cryoablation of the slow AV nodal pathway reduces but does not eliminate this risk compared to radiofrequency. THROMBOEMBOLIC EVENTS: Left-sided procedures (AF ablation, left-sided accessory pathway ablation via transseptal puncture) carry a risk of systemic thromboembolism or stroke (0.5–1%) despite anticoagulation. Pre-procedural TEE or CT to exclude LAA thrombus and meticulous ACT management are essential safeguards. AESOPHAGEAL INJURY: Posterior left atrial ablation during AF procedures risks thermal injury to the adjacent esophagus, ranging from esophageal ulceration to the rare but potentially fatal atrioesophageal fistula (<0.1%). Esophageal temperature monitoring, luminal probe use, and PFA (which spares the esophagus by mechanism) significantly reduce this risk. PHRENIC NERVE INJURY: Right-sided PV isolation and superior vena cava (SVC) isolation may transiently or permanently injure the right phrenic nerve, causing hemidiaphragm paralysis. ARRHYTHMIA RECURRENCE: Catheter ablation is not uniformly curative. Recurrence rates for AF ablation (PVI) range from 20–40% at 1 year for paroxysmal AF, with higher recurrence in persistent AF. Repeat ablation procedures may be required. Success rates are significantly higher for AVNRT (~97%), typical atrial flutter (~95%), and accessory pathway ablation (~95%). RADIATION EXPOSURE: Fluoroscopy-guided EPS involves ionizing radiation. 3D electroanatomical mapping systems substantially reduce fluoroscopy time; zero-fluoroscopy approaches are increasingly adopted at advanced centers and are particularly important for pediatric patients and pregnant patients. GAF Healthcare exclusively partners with centers that maintain 24-hour cardiac surgery backup, intracardiac echocardiography capability, and multidisciplinary arrhythmia boards to minimize and rapidly manage these risks.
Почему GAF Healthcare
GAF Healthcare provides comprehensive end-to-end non-medical coordination for international patients traveling for an Electrophysiology Study, ensuring that every administrative and logistical barrier is eliminated before the patient arrives. VISA & TRAVEL DOCUMENTATION — INDIA: India's e-Medical Visa is available to nationals of 171 countries and is applied for online through the Indian government portal. GAF Healthcare's visa support team prepares and reviews the complete application package — including the official hospital invitation letter from the accredited partner center, treatment cost estimate, and supporting clinical documents — to maximize approval rates. The e-Medical Visa permits a stay of up to 60 days, triple entry, and allows up to two attendants on e-Medical Attendant Visas. Most approvals are issued within 3–5 business days. VISA & TRAVEL DOCUMENTATION — UAE: The UAE offers visa-on-arrival or visa-free access to nationals of over 90 countries (including all EU/EEA nationals, UK, US, Canada, and Australia). GCC nationals require no visa. For nationalities requiring a pre-arranged visa, GAF Healthcare coordinates with the host hospital's international patient office to obtain a UAE medical treatment visa. Dubai and Abu Dhabi are served by two major international airports with direct flights from virtually every major city worldwide, making access uniquely straightforward. AIRPORT TRANSFERS & IN-COUNTRY MOBILITY: GAF Healthcare arranges private, air-conditioned vehicle transfers between the international airport and the partner hospital and between the hospital and the patient's accommodation. All vehicles are GPS-tracked, and a dedicated patient coordinator is present for the arrival pickup. For Indian destinations, inter-city transfers (e.g., Delhi to a specialist center in another city) are arranged by domestic flight or first-class rail as clinically appropriate. DEDICATED MEDICAL INTERPRETERS: For patients whose primary language is Arabic, Russian, French, German, Swahili, or any other non-English language, GAF Healthcare assigns a trained medical interpreter — not a general translator — who accompanies the patient through the consent process, procedure briefing, and discharge education. Interpretation is also available via certified teleinterpreting platforms for rarer languages. ACCOMMODATION FOR PATIENT & ATTENDANT: GAF Healthcare partners with serviced apartments, guesthouses, and hotels adjacent to every partner hospital, offering a range of accommodation from economy (budget-conscious) to five-star (for UAE-tier expectations). All properties are vetted for proximity (within 10–15 minutes of the hospital), cleanliness standards, and availability of dietary accommodation (halal, vegetarian, vegan). During the post-discharge recovery and fit-to-fly observation period, 24-hour helpline access to the GAF Healthcare coordinator ensures any medical concern is immediately escalated to the attending electrophysiologist. CONTINUITY OF CARE: All procedure reports, intracardiac electrogram data, 3D mapping files, and discharge summaries are provided in a structured digital format compatible with international EMR systems. GAF Healthcare facilitates a post-return telemedicine review session between the patient, their home cardiologist, and the treating electrophysiologist at the 4–6 week milestone, ensuring seamless handover of care across geographies.
Частые вопросы о процедуре «Electrophysiology Study»
What is the cost of an Electrophysiology Study (EPS) in India compared to the UAE?
How long do I need to stay in India or the UAE before I am fit to fly home after an EPS?
What is the success rate of an Electrophysiology Study (EPS) and associated catheter ablation?
Похожие страницы
Как GAF Healthcare помогает выбрать лучшую больницу для «electrophysiology study» в Бангалор, Индия
Найдите лучшие больницы для «electrophysiology study» в Бангалор, Индия
На этой странице представлено 10 больниц в Бангалор, Индия, чтобы вы могли сравнить аккредитацию и специализации в одном месте.
Поддержка, когда она нужна
Отправьте нам свои медицинские отчёты в WhatsApp или по email — наша медицинская команда изучит их и предложит больницу и план лечения.
Прозрачные, всё включено цены
Мы предоставляем единую детализированную смету, покрывающую расходы больницы и проживание — без скрытых платежей.
Организация визы, поездки и проживания
После выбора больницы мы помогаем оформить визовое приглашение, забронировать проживание рядом с больницей и организовать трансфер.
Хотите узнать примерную стоимость лечения? Используйте наш калькулятор стоимости для персональной оценки.
Частые вопросы о «Electrophysiology Study» в Бангалор, Индия
Сколько больниц направления «Кардиология» представлено в Бангалор, Индия?
Как вы выбираете больницы для списка?
Сколько стоит лечение в Бангалор, Индия?
Следующий шаг
Отправьте нам свои медицинские отчёты — наша команда предложит больницу и план лечения для «Electrophysiology Study» в Бангалор, Индия.
Свяжитесь с нами, если заметите неточность на этой странице.